Optoretinogram of Single Photoreceptors in the Human Eye

Measurement of dysfunction to inform treatment is within reach.

By Mehdi Azimipour, PhD

Current Applications for Microperimetry for Retinal Disease

Assess the true impact of disease on visual function.

By Victor Gonzalez, MD

Mechanisms of Fluid Development in AMD

Consider the multiple pathways when creating treatment plans.

By Assaf Hilely, MD, Adrian Au, MD, SriniVas R. Sadda, MD, et al.

Fundus Autofluorescence Update and Clinical Applications

Detect abnormalities that may be missed on clinical examination.

By Rohan Jalalizadeh, MD, Alia K. Durrani, MD

Malpractice in Retina

The best protection is providing excellent and ethical care.

By Prashanth G. Iyer, MD, MPH, Jiong Yan, MD, JM, William E. Smiddy, MD, et al.

Interface Vitrectomy for Proliferative Vitreoretinopathy

A variety of procedures can be performed.

By Steve Charles, MD

RETINA CONVERSATIONS: A Conversation With Nancy M. Holekamp of Pepose Vision Institute

Anti-VEGF 2.0 is coming soon.

By Jerry Helzner, contributing editor

Learn to Publish as a Retina Specialist

Prepare yourself for writing peer-reviewed and trade journal articles.

By Benjamin Young, MD, Bilal Ahmed, MD, Jayanth Sridhar, MD

UPFRONT: COVID-19 Vaccines Are on the Way

By Peter K. Kaiser, MD

CLINICAL TRIAL DOWNLOAD: Data on the Axitinib Implant for Wet AMD

Phase 1 results are promising for the dissolvable hydrogel intravitreal implant.

By Yasha Modi, MD , David S. Boyer, MD, Robert L. Avery, MD, et al.

CODING Q&A: The Dos and Don'ts of Advance Beneficiary Notices

Customization and completeness are important factors.

By Suzanne L. Corcoran, COE

CONTROVERSIES IN CARE: The Value of Vitreous and Aqueous Sampling for Culture in Endophthalmitis

Should there be a change in culture?

By Michael Colucciello, MD, Harry W. Flynn Jr., MD, Sunir Garg, MD, FACS, FASRS

NEW PRODUCT APPLICATIONS: The Laser Indirect Ophthalmoscope Gets Reinvented

The first fully integrated laser provides an all-in-one treatment solution for retinal disorders.

By Karen Appold, contributing writer

CLINICAL TRIAL UPDATE

Beovu Meets Endpoints in Phase 3 DME Study

By Jerry Helzner, contributing editor

Faricimab Bispecific Is Durable in Phase 3 DME Studies

By Jerry Helzner, contributing editor

SUBSPECIALTY NEWS: Ultracool anesthesia for IVI, self-reported IVI events, promising data for gene therapies, and more.

By Jerry Helzner, contributing editor

Faculty and CME: Technological Advances in Drug Delivery to Treat Noninfectious Posterior Segment Uveitis

By Michael A. Singer, MD, Seenu M. Hariprasad, MD

Meeting Diagnostic and Management Challenges

Technological Advances in Drug Delivery to Treat Noninfectious Posterior Segment Uveitis

By Michael A. Singer, MD

New Options for Intravitreal Therapy

Technological Advances in Drug Delivery to Treat Noninfectious Posterior Segment Uveitis

By Seenu M. Hariprasad, MD